Difference between revisions of "Team:Austin UTexas/Description"
| Line 23: | Line 23: | ||
<br> | <br> | ||
<div class="column full_size"> | <div class="column full_size"> | ||
| − | <h2 style="color:deepskyblue; text-align: center">Project Description</h2> | + | <h2 style="color:deepskyblue; text-align: center; font-family: verdana">Project Description</h2> |
<html> | <html> | ||
<body> | <body> | ||
| Line 29: | Line 29: | ||
<br> | <br> | ||
| − | <p style= "color:white">The indigenous gut microbiota in humans possesses the ability to synthesize neurotransmitters that are hypothesized to modulate behavioral, cognitive, and emotional processes of the body via the gut-brain axis (1). Since the emergence of this axis theory, researchers have been interested in genetically modifying probiotics for use as edible delivery vehicles of neurotransmitters to treat a variety of illnesses. There is limited experimental evidence regarding the effectiveness of these probiotics in the gut as this is a relatively novel concept. </p> | + | <p style= "color:white; font-family: verdana">The indigenous gut microbiota in humans possesses the ability to synthesize neurotransmitters that are hypothesized to modulate behavioral, cognitive, and emotional processes of the body via the gut-brain axis (1). Since the emergence of this axis theory, researchers have been interested in genetically modifying probiotics for use as edible delivery vehicles of neurotransmitters to treat a variety of illnesses. There is limited experimental evidence regarding the effectiveness of these probiotics in the gut as this is a relatively novel concept. </p> |
<br> | <br> | ||
| − | <p style= "color:white">Thus, our project is aimed at engineering an effective probiotic capable of producing higher levels of gamma-aminobutyric acid (GABA) to treat patients with anxiety and certain bowel disorders. GABA is the neurotransmitter of interest due to its proposed anxiolytic, anti-hypertensive, and digestion-regulating effects (2-4). In order to create an accurate and translational model, we will utilize <i>Lactobacillus plantarum</i> as our probiotic, as it is native to the human gut (5). <i>L. plantarum</i> is also commonly found in a wide variety of foods, including yogurt, kimchi, and cheese, allowing us to easily utilize our genetically-modified version to create medicinal food (6-8). Although <i>L. plantarum</i> can naturally synthesize GABA, we intend to expand the GABA-producing potential of the bacteria by characterizing and subsequently optimizing the expression of glutamate decarboxylase, an enzyme responsible for converting glutamate into GABA (9). </p> | + | <p style= "color:white; font-family: verdana">Thus, our project is aimed at engineering an effective probiotic capable of producing higher levels of gamma-aminobutyric acid (GABA) to treat patients with anxiety and certain bowel disorders. GABA is the neurotransmitter of interest due to its proposed anxiolytic, anti-hypertensive, and digestion-regulating effects (2-4). In order to create an accurate and translational model, we will utilize <i>Lactobacillus plantarum</i> as our probiotic, as it is native to the human gut (5). <i>L. plantarum</i> is also commonly found in a wide variety of foods, including yogurt, kimchi, and cheese, allowing us to easily utilize our genetically-modified version to create medicinal food (6-8). Although <i>L. plantarum</i> can naturally synthesize GABA, we intend to expand the GABA-producing potential of the bacteria by characterizing and subsequently optimizing the expression of glutamate decarboxylase, an enzyme responsible for converting glutamate into GABA (9). </p> |
<div class="column full_size_outer"> | <div class="column full_size_outer"> | ||
| Line 45: | Line 45: | ||
<div class="column-left"> | <div class="column-left"> | ||
| − | <h4 style="font-size:22px;text-align: center">Part Plasmid Assembly</h4> | + | <h4 style="font-size:22px;text-align: center; font-family: verdana">Part Plasmid Assembly</h4> |
<br> | <br> | ||
<a href="https://2017.igem.org/Team:Austin_UTexas/PartPlasmids"> <img src="https://static.igem.org/mediawiki/2017/4/4f/T--Austin_UTexas--gadBAndPromoterPartPlasmids.jpg" style="width:100%;"></a></center> | <a href="https://2017.igem.org/Team:Austin_UTexas/PartPlasmids"> <img src="https://static.igem.org/mediawiki/2017/4/4f/T--Austin_UTexas--gadBAndPromoterPartPlasmids.jpg" style="width:100%;"></a></center> | ||
| Line 63: | Line 63: | ||
<br> | <br> | ||
| − | <h5 style="color:deepskyblue">References</h5> | + | <h5 style="color:deepskyblue; font-family: verdana">References</h5> |
| − | <ol style="font-size:11px"> | + | <ol style="font-size:11px; font-family: verdana"> |
<li> Mayer E. A. et al. Gut Microbes and the Brain: Paradigm Shift in Neuroscience. <i>J Neurosci.</i>34(46): 15490-96 (2014). </li> | <li> Mayer E. A. et al. Gut Microbes and the Brain: Paradigm Shift in Neuroscience. <i>J Neurosci.</i>34(46): 15490-96 (2014). </li> | ||
Revision as of 04:44, 30 October 2017
Project Description
The indigenous gut microbiota in humans possesses the ability to synthesize neurotransmitters that are hypothesized to modulate behavioral, cognitive, and emotional processes of the body via the gut-brain axis (1). Since the emergence of this axis theory, researchers have been interested in genetically modifying probiotics for use as edible delivery vehicles of neurotransmitters to treat a variety of illnesses. There is limited experimental evidence regarding the effectiveness of these probiotics in the gut as this is a relatively novel concept.
Thus, our project is aimed at engineering an effective probiotic capable of producing higher levels of gamma-aminobutyric acid (GABA) to treat patients with anxiety and certain bowel disorders. GABA is the neurotransmitter of interest due to its proposed anxiolytic, anti-hypertensive, and digestion-regulating effects (2-4). In order to create an accurate and translational model, we will utilize Lactobacillus plantarum as our probiotic, as it is native to the human gut (5). L. plantarum is also commonly found in a wide variety of foods, including yogurt, kimchi, and cheese, allowing us to easily utilize our genetically-modified version to create medicinal food (6-8). Although L. plantarum can naturally synthesize GABA, we intend to expand the GABA-producing potential of the bacteria by characterizing and subsequently optimizing the expression of glutamate decarboxylase, an enzyme responsible for converting glutamate into GABA (9).
Part Plasmid Assembly
We had to construct various part plasmids in order to use them in Golden Gate Assembly.
Working with L. plantarum
Our proposed bacteria for over expression of GABA in the human gut is L. plantarum, a probiotic..
References
- Mayer E. A. et al. Gut Microbes and the Brain: Paradigm Shift in Neuroscience. J Neurosci.34(46): 15490-96 (2014).
- Bravo, J. A. et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 108(38): 16050-5 (2011).
- Shimada M. et al Anti-hypertensive effect of gamma-aminobutyric acid (GABA)- rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study. Clin Exp Hypertens. 21(4): 342-54 (2009).
- Auteri M. et al. GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation. Pharmacological Research. 93: 11-21 (2015).
- De Vries, M. et al. Lactobacillus plantarum - survival, functional and potential probiotic properties in the human intestinal tract. International Dairy Journal. 16(0): 1018-1028 (2006).
- Shan, Y. et al. Evaluation of improved gamma-aminobutyric acid production in yogurt using Lactobacillus plantarum NDC75017. J Dairy Sci. 98(4): 2138-49 (2015).
- Siragusa, S. et al. Synthesis of gamma-aminobutyric acid by lactic acid bacteria isolated from a variety of italian cheeses. Appl Environ Microbiol. 73(22): 7283-90 (2007).
- Yoon, J. H. Lactobacillus kimchii sp. Nov., a new species from kimchi. Int J Syst Evol Microbiol. 50: 1789-95 (2000).
- Yunes, R. A. GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota. Anaerobe. 42: 197-204 (2016).
